imatinib mesylate has been researched along with Anus Neoplasms in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 9 (81.82) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Alassani, F; Bagny, A; Darré, T; Djiwa, T; Napo-Koura, G; Tchangaï, B; Tchaou, M | 1 |
| Agaimy, A; Croner, RS; Haller, F; Hohenberger, W; Köhler, J; Märkl, B; Matzel, K; Meidenbauer, N; Schneider-Stock, R; Spatz, J; Vassos, N | 1 |
| Henderson, M; Heriot, AG; Knowles, J; Lynch, AC; Warrier, SK | 1 |
| Glasgow, SC; Hawkins, AT; Hunt, SR; Krishnamurty, DM; Mutch, MG; Silviera, ML; Wells, KO; Wise, PE | 1 |
| Fujimura, T; Fukushima, W; Izumi, R; Kitagawa, H; Maruzen, S; Sasaki, S; Terada, I; Yagi, Y; Yoshikawa, A | 1 |
| Bastian, BC; Bauer, J; Lutzky, J | 1 |
| Gutzmer, R; Kapp, A; Küttler, U; Satzger, I; Schenck, F; Völker, B | 1 |
| Huang, MJ; Kang, L; Wang, JP; Wang, L; Wang, T; Wu, XJ | 1 |
| Dummer, R; Schoenewolf, NL; Urosevic-Maiwald, M | 1 |
| Arifi, S; El Mesbahi, O; Errihani, H; Tazi, el M | 1 |
| Centonze, D; Cinardi, N; Franco, S; Giannone, G; Pulvirenti D'Urso, A; Pulvirenti, E | 1 |
1 review(s) available for imatinib mesylate and Anus Neoplasms
| Article | Year |
|---|---|
Anal mucosal melanoma with KIT-activating mutation and response to imatinib therapy--case report and review of the literature.
Topics: Aged; Antineoplastic Agents; Anus Neoplasms; Benzamides; Female; Humans; Imatinib Mesylate; Melanoma; Mucous Membrane; Mutation; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Skin Neoplasms | 2010 |
10 other study(ies) available for imatinib mesylate and Anus Neoplasms
| Article | Year |
|---|---|
Anal Canal Gastrointestinal Stromal Tumor: a Case Report.
Topics: Adult; Anal Canal; Anus Neoplasms; Chemotherapy, Adjuvant; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Magnetic Resonance Imaging; Male; Treatment Outcome | 2021 |
Anorectal gastrointestinal stromal tumors: a retrospective multicenter analysis of 15 cases emphasizing their high local recurrence rate and the need for standardized therapeutic approach.
Topics: Anus Neoplasms; Base Sequence; Benzamides; Female; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Molecular Sequence Data; Neoplasm Recurrence, Local; Piperazines; Pyrimidines; Radiography; Rectal Neoplasms; Reference Standards; Retrospective Studies; Treatment Outcome | 2013 |
A case series of anal melanoma including the results of treatment with imatinib in selected patients.
Topics: Adult; Aged; Aged, 80 and over; Anal Canal; Antineoplastic Agents; Anus Neoplasms; Dacarbazine; Digestive System Surgical Procedures; Disease-Free Survival; Female; Humans; Imatinib Mesylate; Kaplan-Meier Estimate; Male; Melanoma; Middle Aged; Mutation; Neoplasm Staging; Niacinamide; Phenylurea Compounds; Proto-Oncogene Proteins c-kit; Retrospective Studies; Sorafenib; Survival Rate | 2016 |
Preoperative Chemotherapy and Survival for Large Anorectal Gastrointestinal Stromal Tumors: A National Analysis of 333 Cases.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Anus Neoplasms; Chemotherapy, Adjuvant; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Neoadjuvant Therapy; Rectal Neoplasms; Survival Rate; Tumor Burden; United States; Young Adult | 2017 |
[A Case of Gastrointestinal Stromal Tumor(GIST)Originating in the Anal Canal].
Topics: Aged; Antineoplastic Agents; Anus Neoplasms; Chemotherapy, Adjuvant; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Mutation; Proto-Oncogene Proteins c-kit | 2016 |
Dose-dependent, complete response to imatinib of a metastatic mucosal melanoma with a K642E KIT mutation.
Topics: Aged; Amino Acid Substitution; Anus Neoplasms; Benzamides; Dose-Response Relationship, Drug; Female; Glutamic Acid; Humans; Imatinib Mesylate; Intestinal Mucosa; Lysine; Melanoma; Neoplasm Metastasis; Piperazines; Point Mutation; Proto-Oncogene Proteins c-kit; Pyrimidines; Remission Induction | 2008 |
The role of neoadjuvant imatinib mesylate therapy in sphincter-preserving procedures for anorectal gastrointestinal stromal tumor.
Topics: Adult; Aged; Anal Canal; Antineoplastic Agents; Anus Neoplasms; Benzamides; Feasibility Studies; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Neoadjuvant Therapy; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Rectal Neoplasms; Treatment Outcome | 2011 |
Tumour heterogeneity of mucosal melanomas during treatment with imatinib.
Topics: Aged; Antineoplastic Agents; Anus Neoplasms; Benzamides; Fatal Outcome; Female; Humans; Imatinib Mesylate; Male; Melanoma; Middle Aged; Mutation; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Rectal Neoplasms; Treatment Outcome; Tumor Cells, Cultured; Vulvar Neoplasms | 2011 |
Activity of Imatinib Mesylate in Metastatic Anorectal Melanoma: A Case Report.
Topics: Antineoplastic Agents; Anus Neoplasms; Humans; Imatinib Mesylate; Male; Melanoma; Middle Aged; Prognosis; Rectal Neoplasms; Tomography, X-Ray Computed | 2012 |
Local excision with adjuvant imatinib therapy for anorectal gastrointestinal stromal tumors.
Topics: Aged; Anus Neoplasms; Benzamides; Chemotherapy, Adjuvant; Colectomy; Combined Modality Therapy; Endosonography; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Piperazines; Positron-Emission Tomography; Pyrimidines; Rectal Neoplasms; Risk Assessment; Sampling Studies; Tomography, X-Ray Computed; Treatment Outcome | 2013 |